Nag Research Labs
Nag Research Labs is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Nag Research Labs.
Nag Research Labs is a company.
Key people at Nag Research Labs.
Key people at Nag Research Labs.
Nag Research Laboratories (NRL) is a biotechnology company based in Fremont, California, specializing in IP-driven R&D for life sciences, biotech, and pharmaceuticals.[1][2][3] Founded and led by Dr. Bishwajit Nag as Chairman and CEO, NRL focuses on new drug discovery, novel biotechnology products, patented herbal and cosmeceutical formulations, and research tools like specialized kits and reagents for electrophoresis, electro-blotting, and protein biochemistry.[1][3][7][9] It serves industries including dietary supplements, nutraceuticals, and pharma through partnerships, such as with GCI Nutrients and Herbalyn Life Sciences, developing clinically tested botanical-based formulas.[1][2]
With over three decades of R&D experience, NRL addresses challenges in molecular biology, natural product discoveries, and herbal formulations, leveraging Dr. Nag's extensive patent portfolio and collaborations with top institutions.[1][2]
NRL was founded by Dr. Bishwajit Nag, a distinguished scientist with a BSc in Chemistry (Honours) with Biology and MSc in Biochemistry from Banaras Hindu University, India, followed by a PhD in Molecular Biology/Biochemistry under Nobel Laureate Dr. Severo Ochoa.[1] His career includes roles as an NIH scientist at UC Davis (1984-1986), developing epitope-based monoclonal antibodies, and establishing collaborations with Harvard Medical School, Stanford, UCLA, UC-Berkeley, Vanderbilt, and Johns Hopkins.[1]
The company emerged from Dr. Nag's expertise in protein synthesis mechanisms, biotechnology, and natural products, evolving into a fully integrated R&D firm in the San Francisco Bay Area focused on innovative life science products.[1][2] Early traction is evidenced by over 200 peer-reviewed publications and 100+ US/international patents, with pivotal partnerships like his role as Chief Science Officer at GCI Nutrients highlighting NRL's integration into broader nutraceutical ecosystems.[1]
NRL rides the wave of nutraceuticals, herbal biotech, and personalized life sciences, capitalizing on rising demand for natural, clinically validated supplements amid growing wellness and preventive health trends.[1] Its timing aligns with post-pandemic emphasis on immune-boosting botanicals and IP-protected formulations, fueled by market forces like regulatory support for evidence-based herbals and global supply chain needs for US-based R&D.[1][2]
By providing research tools and formulations, NRL influences the biotech ecosystem, enabling faster innovation for dietary supplement firms and bridging academic research with commercial products through elite networks.[1][7]
NRL's trajectory points toward expanded partnerships in nutraceuticals and pharma, leveraging Dr. Nag's leadership for new IP in herbal drugs and biotech tools amid aging populations and natural product booms.[1] Trends like AI-driven drug discovery and sustainable botanicals will shape its path, potentially amplifying influence via global scaling of formulations.[1][3] As an early-stage player with proven patents, NRL remains poised to deepen ecosystem impact, echoing its founding mission of technology-driven life science breakthroughs.[1][2]